ICL Misses On Sales And EPS As Growth Stalls, While Bromine Strength And A Guidance Lean Keep A 2027 Story Alive
ICL Group reported Q3 adjusted EPS of $0.10, missing estimates by 9.1%, with revenue of $1.91B, down 10.3% from consensus. Growth slowed across most segments except Industrial Products, which saw 18% sales growth. Management maintained full-year guidance, citing bromine strength and cost savings. Shares fell 11.4% post-earnings.
How this was made

The 30-second read
Why it matters
The earnings miss drives short‑term downside risk, but the company's industrial products segment and cost‑saving initiatives could support a recovery.
Market read
The earnings miss is material for traders holding or shorting ICL, with limited spillover to the broader sector.
What to watch
Sulfur cost decline and 2027 savings target may provide a longer‑term tailwind not reflected in the immediate price move.
Background
ICL Group reported Q3 results that fell short of consensus, with revenue and EPS misses and slowing segment growth.
Ticker impact
Q3 earnings miss on revenue and EPS, guidance unchanged, indicating near‑term pressure on the stock.
likely pressure as the market prices in weaker sales and EPS
The company posted revenue $1.91B vs $2.13B consensus and EPS $0.10 vs $0.11 consensus, with guidance unchanged, prompting a negative reaction.
Market effects
Minerals sector may see broader scrutiny as growth stalls in diversified producers.
Potential impact on Israeli and broader Middle‑East commodity exporters.
Limited to investors in fertilizer and specialty chemicals.
Counterpoint
If industrial products sustain strong bromine pricing, the stock could rebound on the upside.
Key entities
- companyICL Group Ltd.
Diversified minerals producer reporting Q3 earnings.




